ArticleOne health (Amsterdam, Netherlands)2025
Leptospirosis? An epidemiologic investigation following the historic 2024 floods in Rio Grande do Sul, Brazil.
Article in One health (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Epidemiological Scenario of Human Leptospirosis in Brazil from 2015 to 2024.Epidemiologia (Basel, Switzerland) · 2026Article
- [Floods in Rio Grande do Sul State, Brazil, in 2024 and their effects on the epidemiology of leptospirosis].Cadernos de saude publica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
In May 2024, the Brazilian state of Rio Grande do Sul experienced an historic flood that affected millions of people. Hundreds of thousands of people were displaced by the record-breaking flood waters, exposing them to water-borne pathogens, including leptospirosis. With concern for an outbreak, local efforts focused on identifying and treating any potential cases of leptospirosis. Using data from a local database for people presenting with signs and symptoms compatible with leptospirosis, we conducted a retrospective-prospective cohort study to estimate the incidence of confirmed cases. Of 539 patients reported to the database, a total of 485 patients were tested for leptospirosis and 303 were tested for Dengue (with 283 testing for both pathogens). We found 17 (3.5 %) confirmed cases of leptospirosis and 102 (33.7 %) confirmed cases of dengue fever. Most tested negative for both, with several confirmed cases of Hantavirus, Influenza A, and HIV. Although there were no significant differences between diagnoses and exposure risk factors, we did find several clinical differences, including headache, respiratory symptoms, diarrhea, acute kidney injury, jaundice, bleeding diathesis, and pulmonary hemorrhage. Leptospirosis was also found to be significantly associated with adverse clinical outcomes when compared to both dengue and the Unrelated/Unknown illness group and more likely to be of the male sex. These data reinforce the need for broader systematic surveillance for pathogens that may circulate in the event of major environmental disasters. Further, stronger diagnostics are urgently needed to distinguish between the causes of largely febrile outbreak in the face of a changing climate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.